Literature DB >> 15936978

Delivery of bone morphogenetic proteins for orthopedic tissue regeneration.

Howard Seeherman1, John M Wozney.   

Abstract

Carriers for bone morphogenetic proteins (BMPs) are used to increase retention of these factors at orthopedic treatment sites for a sufficient period of time to allow regenerative tissue forming cells to migrate to the area of injury and to proliferate and differentiate. Carriers can also serve as a matrix for cell infiltration while maintaining the volume in which repair tissue can form. Carriers have to be biocompatible and are often required to be bioresorbable. Carriers also have to be easily, and cost-effectively, manufactured for large-scale production, conveniently sterilized and have appropriate storage requirements and stability. All of these processes have to be approvable by regulatory agencies. The four major categories of BMP carrier materials include natural polymers, inorganic materials, synthetic polymers, composites of these materials. Autograft or allograft carriers have also used. Carrier configurations range from simple depot delivery systems to more complex systems mimicking the extracellular matrix structure and function. Bone regenerative carriers include depot delivery systems for fracture repair, three-dimensional polymer or ceramic composites for segmental repairs and spine fusion and metal or metal/ceramic composites for augmenting implant integration. Tendon/ligament regenerative carriers range from depot delivery systems to three-dimensional carriers that are either randomly oriented or linearly oriented to improve regenerative tissue alignment. Cartilage regenerative systems generally require three-dimensional matrices and often incorporate cells in addition to factors to augment the repair. Alternative BMP delivery systems include viral vectors, genetically altered cells, conjugated factors and small molecules.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15936978     DOI: 10.1016/j.cytogfr.2005.05.001

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  73 in total

Review 1.  Strategies for controlled delivery of growth factors and cells for bone regeneration.

Authors:  Tiffany N Vo; F Kurtis Kasper; Antonios G Mikos
Journal:  Adv Drug Deliv Rev       Date:  2012-02-04       Impact factor: 15.470

2.  Bioglass as a carrier for reindeer bone protein extract in the healing of rat femur defect.

Authors:  Hanna Tölli; Sauli Kujala; Katri Levonen; Timo Jämsä; Pekka Jalovaara
Journal:  J Mater Sci Mater Med       Date:  2010-02-17       Impact factor: 3.896

3.  High-strength, in situ-setting calcium phosphate composite with protein release.

Authors:  Michael D Weir; Hockin H K Xu
Journal:  J Biomed Mater Res A       Date:  2008-05       Impact factor: 4.396

4.  Adverse effects of posterior lumbar interbody fusion using rhBMP-2.

Authors:  Tomislav Smoljanovic; Ivan Bojanic; Domagoj Delimar
Journal:  Eur Spine J       Date:  2009-04-08       Impact factor: 3.134

5.  Heparin-dopamine functionalized graphene foam for sustained release of bone morphogenetic protein-2.

Authors:  Qingqing Yao; Yangxi Liu; Hongli Sun
Journal:  J Tissue Eng Regen Med       Date:  2018-05-18       Impact factor: 3.963

6.  Comparison of the effects of recombinant human bone morphogenetic protein-2 and -9 on bone formation in rat calvarial critical-size defects.

Authors:  Toshiaki Nakamura; Yoshinori Shirakata; Yukiya Shinohara; Richard J Miron; Kozue Hasegawa-Nakamura; Masako Fujioka-Kobayashi; Kazuyuki Noguchi
Journal:  Clin Oral Investig       Date:  2017-02-14       Impact factor: 3.573

7.  Tribute to Dr. Marshall Urist: musculoskeletal growth factors: editorial comment.

Authors:  Feza Korkusuz
Journal:  Clin Orthop Relat Res       Date:  2009-12       Impact factor: 4.176

8.  Rational design of hydrogels to enhance osteogenic potential.

Authors:  Soyon Kim; Min Lee
Journal:  Chem Mater       Date:  2020-11-05       Impact factor: 9.811

Review 9.  Drug delivery using composite scaffolds in the context of bone tissue engineering.

Authors:  Cecilia Romagnoli; Federica D'Asta; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2013-09

10.  Effect of low-intensity pulsed ultrasound on scaffold-free ectopic bone formation in skeletal muscle.

Authors:  Munenori Watanuki; Koshi N Kishimoto; Satoshi Kotajima; Sadahiro Iwabuchi; Shoichi Kokubun
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.